Prospective Study on Body Composition, Energy Balance and Biological Factors Changes in Post-menopausal Women with Breast Cancer Receiving Adjuvant Chemotherapy Including Taxanes

References

• Majed B, Moreau T, and Asselain B. Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points. Breast Cancer Res Treat 115, 193–203, 2009.
   PubMed Web of Science ®Google Scholar
• Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, et al.: Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 111, 329–342, 2008.
   PubMed Web of Science ®Google Scholar
• Goodwin PJ, Ennis M, Pritchard KI, McCready D, Koo J, et al.: Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 17, 120–129, 1999.
   PubMed Web of Science ®Google Scholar
• Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, et al.: Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev 18, 1403–1409, 2009.
   PubMed Web of Science ®Google Scholar
• Thivat E, Therondel S, Lapirot O, Abrial C, Gimbergues P, et al.: Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer 10, 648, 2010.
   PubMed Web of Science ®Google Scholar
• Gadea E, Thivat E, Planchat E, Morio B, and Durando X: Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms. Obes Rev 13, 368–380, 2012.
   PubMed Web of Science ®Google Scholar
• Gadea E, Thivat E, Paulon R, Mishellany F, Gimbergues P, et al.: Hibernoma: a clinical model for exploring the role of brown adipose tissue in the regulation of body weight? J Clin Endocrinol Metab 99, 1–6, 2014.
   PubMed Web of Science ®Google Scholar
• Gryson C, Ratel S, Rance M, Penando S, Bonhomme C, et al.: Four-month course of soluble milk proteins interacts with exercise to improve muscle strength and delay fatigue in elderly participants. J Am Med Dir Assoc 15, 958 e951–e959, 2014.
   PubMed Web of Science ®Google Scholar
• De Pergola G, and Silvestris F: Obesity as a major risk factor for cancer. J Obes 2013, 291546, 2013.
   PubMedGoogle Scholar
• Tredan O, Bajard A, Meunier A, Roux P, Fiorletta I, et al.: Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study. Clin Nutr 29,187–191, 2010.
   PubMed Web of Science ®Google Scholar
• Heideman WH, Russell NS, Gundy C, Rookus MA, and Voskuil DW: The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors. Eur J Cancer 45,119–126, 2009.
   PubMed Web of Science ®Google Scholar
• Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, et al.: Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 19, 2381–2389, 2001.
   PubMed Web of Science ®Google Scholar
• Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, et al.: Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol 23, 774–782, 2005.
   PubMed Web of Science ®Google Scholar
• Saquib N, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, et al.: Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women's healthy eating and living (WHEL) study. Breast Cancer Res Treat 105, 177–186, 2007.
   PubMed Web of Science ®Google Scholar
• Pedersen B, Delmar C, Bendtsen MD, Bosaeus I, Carus A, et al.: Changes in weight and body composition among women with breast cancer during and after adjuvant treatment: a prospective follow-up study. Cancer Nurs 40, 369–376, 2017.
   PubMed Web of Science ®Google Scholar
• Chaudhary LN, Wen S, Xiao J, Swisher AK, Kurian S, et al.: Weight change associated with third-generation adjuvant chemotherapy in breast cancer patients. J Community Support Oncol 12, 355–360, 2014.
   PubMedGoogle Scholar
• Jeon YW, Lim ST, Choi HJ, and Suh YJ: Weight change and its impact on prognosis after adjuvant TAC (docetaxel-doxorubicin-cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer. Med Oncol 31, 849, 2014.
   PubMed Web of Science ®Google Scholar
• Ladoire S, Dalban C, Roche H, Spielmann M, Fumoleau P, et al.: Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trials. Eur J Cancer 50, 506–516, 2014.
   PubMed Web of Science ®Google Scholar
• Campbell KL, Lane K, Martin AD, Gelmon KA, and McKenzie DC: Resting energy expenditure and body mass changes in women during adjuvant chemotherapy for breast cancer. Cancer Nurs 30, 95–100, 2007.
   PubMed Web of Science ®Google Scholar
• Harvie MN, Campbell IT, Baildam A, and Howell A: Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 83, 201–210, 2004.
   PubMed Web of Science ®Google Scholar
• Borugian MJ, Sheps SB, Kim-Sing C, Olivotto IA, Van Patten C, et al.: Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 158, 963–968, 2003.
   PubMed Web of Science ®Google Scholar
• Folsom AR, Kaye SA, Sellers TA, Hong CP, Cerhan JR, et al.: Body fat distribution and 5-year risk of death in older women. JAMA 269, 483–487, 1993.
   PubMed Web of Science ®Google Scholar
• Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, et al.: Factors associated with weight gain in women after diagnosis of breast cancer. Women's healthy eating and living study group. J Am Diet Assoc 99, 1212–1221, 1999.
   PubMed Web of Science ®Google Scholar
• Makari-Judson G, Judson CH, Mertens WC: Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year. Breast J 13, 258–265, 2007.
   PubMed Web of Science ®Google Scholar
• Nissen MJ, Shapiro A, and Swenson KK: Changes in weight and body composition in women receiving chemotherapy for breast cancer. Clin Breast Cancer 11, 52–60, 2011.
   PubMed Web of Science ®Google Scholar
• Chevalier S, Marliss EB, Morais JA, Lamarche M, and Gougeon R: Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr 82, 355–365, 2005.
   PubMed Web of Science ®Google Scholar
• Guillet C, Delcourt I, Rance M, Giraudet C, Walrand S, et al.: Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. J Clin Endocrinol Metab 94, 3044–3050, 2009.
   PubMed Web of Science ®Google Scholar
• Chaston TB, Dixon JB, and O'Brien PE: Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond) 31, 743–750, 2007.
   PubMed Web of Science ®Google Scholar
• Dubnov-Raz G, and Berry EM: Dietary approaches to obesity. Mt Sinai J Med 77, 488–498, 2010.
   PubMed Web of Science ®Google Scholar
• Lucia S, Esposito M, Rossi Fanelli F, and Muscaritoli M: Cancer cachexia: from molecular mechanisms to patient's care. Crit Rev Oncog 17, 315–321, 2012.
   PubMedGoogle Scholar
• Janssen I, Fortier A, Hudson R, and Ross R: Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care 25, 431–438, 2002.
   PubMed Web of Science ®Google Scholar
• Caan BJ, Kwan ML, Hartzell G, Castillo A, Slattery ML, et al.: Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control 19, 1319–1328, 2008.
   PubMed Web of Science ®Google Scholar
• Carmichael AR: Obesity and prognosis of breast cancer. Obes Rev 7, 333–340, 2006.
   PubMed Web of Science ®Google Scholar
• Arpino G, De Angelis C, Buono G, Colao A, Giuliano M, et al.: Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy. Breast Cancer Res Treat 154, 127–132, 2015.
   PubMed Web of Science ®Google Scholar
• Irwin ML, Crumley D, McTiernan A, Bernstein L, Baumgartner R, et al.: Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 97, 1746–1757, 2003.
   PubMed Web of Science ®Google Scholar
• Foucaut AM, Berthouze SE, Touillaud M, Morelle M, Bourne-Branchu V, et al.: Deterioration of physical activity level and metabolic risk factors after early-stage breast cancer diagnosis. Cancer Nurs 38, E1–E9, 2015.
   PubMed Web of Science ®Google Scholar
• Kim RB, Phillips A, Herrick K, Helou M, Rafie C, et al.: Physical activity and sedentary behavior of cancer survivors and non-cancer individuals: results from a national survey. PLoS One 8, e57598, 2013.
   PubMed Web of Science ®Google Scholar
• Hamilton MT, Hamilton DG, and Zderic TW. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56, 2655–2667, 2007.
   PubMed Web of Science ®Google Scholar
• Healy GN, Dunstan DW, Salmon J, Shaw JE, Zimmet PZ, et al.: Television time and continuous metabolic risk in physically active adults. Med Sci Sports Exerc 40, 639–645, 2008.
   PubMed Web of Science ®Google Scholar
• Healy GN, Matthews CE, Dunstan DW, Winkler EA, and Owen N: Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06. Eur Heart J 32, 590–597, 2011.
   PubMed Web of Science ®Google Scholar
• Kesaniemi YK, Danforth E, Jr., Jensen MD, Kopelman PG, Lefebvre P, et al.: Dose-response issues concerning physical activity and health: an evidence-based symposium. Med Sci Sports Exerc 33, S351–S358, 2001.
   PubMed Web of Science ®Google Scholar
• Bey L and Hamilton MT: Suppression of skeletal muscle lipoprotein lipase activity during physical inactivity: a molecular reason to maintain daily low-intensity activity. J Physiol (Lond.) 551, 673–682, 2003.
   Google Scholar
• Yanagibori R, Suzuki Y, Kawakubo K, Kondo K, Iwamoto T, et al.: The effects of 20 days bed rest on serum lipids and lipoprotein concentrations in healthy young subjects. J Gravit Physiol 4, S82–S90, 1997.
   PubMedGoogle Scholar
• Gilliam LA, Fisher-Wellman KH, Lin CT, Maples JM, Cathey BL, et al.: The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle. Free Radic Biol Med 65, 988–996, 2013.
   PubMed Web of Science ®Google Scholar
• Gadea E, Ginzac A, Herviou P, Thivat E, Arbre M, et al.: Weight change during breast cancer treatment is it always of poor prognosis? Corresp MHDN 19, 298–301, 2015.
   Google Scholar